Universal Health (UHS) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $5.98
- EPS estimate
- $5.94
- EPS surprise
- +0.67%
- Revenue surprise
- +1.29%
- Revenue
- $4.6B
- Revenue estimate
- $4.6B
- Reported
- Jul 28, 2026
Universal Health reported Q2 2026 results on July 28, 2026. Earnings per share were $5.98, just above the $5.94 estimate by 0.67%. Revenue was $4.6 billion, 1.29% ahead of the consensus. Compared with Q2 2025, EPS rose about 12% from $5.35 and revenue rose about 7% from $4.3 billion. Q2 2026 set the highs in the table for both EPS and revenue.
Annual EPS rose from $9.91 in 2022 to $10.55 in 2023, then jumped to $16.64 in 2024 and $21.76 in 2025. Annual revenue grew each year, from $13.3 billion to $17.4 billion. The first half of 2026 adds up to $11.60, about 14% more than the same period a year earlier. The low point in the table was Q1 2022, at $2.15 per share. Quarterly EPS has nearly tripled since then. Over the last 20 quarters, Universal Health topped the EPS estimate 16 times. The largest beat was Q2 2024, at 30.49%. The largest miss was Q1 2022.
Universal Health reported Q3 between October 25 and October 28 in each of the past five years. That points to late October 2026 for the next report. It will show whether the year-over-year growth of the first half continues.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 28, 2026 | $5.94 | $5.98 | +0.67% | $4.6B | SEC |
| Q1 2026 | Apr 28, 2026 | $5.41 | $5.62 | +3.91% | $4.5B | SEC |
| Q4 2025 | Feb 25, 2026 | $5.86 | $5.88 | +0.35% | $4.5B | SEC |
| Q3 2025 | Oct 28, 2025 | $4.88 | $5.69 | +16.64% | $4.5B | SEC |
| Q2 2025 | Jul 29, 2025 | $4.92 | $5.35 | +8.80% | $4.3B | SEC |
| Q1 2025 | Apr 29, 2025 | $4.35 | $4.84 | +11.21% | $4.1B | SEC |
| Q4 2024 | Feb 26, 2025 | $4.16 | $4.92 | +18.26% | $4.1B | SEC |
| Q3 2024 | Oct 25, 2024 | $3.72 | $3.71 | −0.18% | $4.0B | SEC |
| Q2 2024 | Jul 25, 2024 | $3.30 | $4.31 | +30.49% | $3.9B | SEC |
| Q1 2024 | Apr 25, 2024 | $3.15 | $3.70 | +17.61% | $3.8B | SEC |
| Q4 2023 | Feb 27, 2024 | $2.89 | $3.13 | +8.28% | $3.7B | SEC |
| Q3 2023 | Oct 26, 2023 | $2.37 | $2.55 | +7.59% | $3.6B | SEC |
| Q2 2023 | Jul 26, 2023 | $2.43 | $2.53 | +3.96% | $3.5B | SEC |
| Q1 2023 | Apr 26, 2023 | $2.20 | $2.34 | +6.61% | $3.5B | SEC |
| Q4 2022 | Feb 27, 2023 | $2.96 | $3.02 | +1.95% | $3.4B | SEC |
| Q3 2022 | Oct 25, 2022 | $2.43 | $2.54 | +4.51% | $3.3B | SEC |
| Q2 2022 | Jul 26, 2022 | $2.35 | $2.20 | −6.36% | $3.3B | SEC |
| Q1 2022 | Apr 26, 2022 | $2.47 | $2.15 | −13.11% | $3.3B | SEC |
| Q4 2021 | Feb 24, 2022 | $2.87 | $2.95 | +2.79% | $3.3B | SEC |
| Q3 2021 | Oct 26, 2021 | $2.75 | $2.67 | −2.97% | $3.2B | SEC |
Quarterly revenue
Frequently asked questions
When did Universal Health (UHS) last report earnings?
Universal Health last reported on Jul 28, 2026, covering fiscal Q2 2026.
Did UHS beat earnings estimates?
Yes. Universal Health reported EPS of $5.98 for Q2 2026 against a $5.94 estimate — a 0.67% beat.
How much revenue did UHS report last quarter?
Universal Health reported $4.6B in revenue for Q2 2026, against a consensus estimate of $4.6B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.